Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Romanelli

Showing results (251-260 of 310) with videos related to

Pageof 31
Sort By:
Vaccines|April 28, 2023
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Drugs & Aging|July 23, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
International Wound Journal|May 13, 2009
Dilemmas in measuring and using pressure ulcer prevalence and incidence: an international consensusMona M Baharestani, Joyce M Black, Keryln Carville, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 16, 2023
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective studyMartina Dragotto, Eugenio Capalbo, Alessandra Cartocci, et al.
Italian Journal of Dermatology and Venereology|November 7, 2024
Risankizumab in very elderly patients in real-world practiceElisa Lorenzoni, Antonella Di Cesare, Elia Rosi, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort StudyFlaminia Antonelli, Elena Ippoliti, Elia Rosi, et al.
Dermatology and Therapy|May 21, 2023
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi ConsensusGiovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
International Wound Journal|March 11, 2026
Implementing Wound Hygiene in the Italian Healthcare Context: Expert Recommendations for the Management of Venous Leg UlcersAlessandro Scalise, Franco Bassetto, Diego Ceci, et al.
Pageof 31

Showing results (251-260 of 310) with videos related to

Sort By:
Pageof 31
Vaccines|April 28, 2023
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, et al.
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Drugs & Aging|July 23, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
International Wound Journal|May 13, 2009
Dilemmas in measuring and using pressure ulcer prevalence and incidence: an international consensusMona M Baharestani, Joyce M Black, Keryln Carville, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 16, 2023
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective studyMartina Dragotto, Eugenio Capalbo, Alessandra Cartocci, et al.
Italian Journal of Dermatology and Venereology|November 7, 2024
Risankizumab in very elderly patients in real-world practiceElisa Lorenzoni, Antonella Di Cesare, Elia Rosi, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort StudyFlaminia Antonelli, Elena Ippoliti, Elia Rosi, et al.
Dermatology and Therapy|May 21, 2023
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi ConsensusGiovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
International Wound Journal|March 11, 2026
Implementing Wound Hygiene in the Italian Healthcare Context: Expert Recommendations for the Management of Venous Leg UlcersAlessandro Scalise, Franco Bassetto, Diego Ceci, et al.
Pageof 31